Cyanotech Corporation (CYBE) is a microalgae company publicly traded on the over-the-counter (OTC) market and tracked on Yahoo Finance. Founded in 1983 and headquartered in Kailua-Kona, Hawaii, Cyanotech specializes in the production of high-value nutritional and health products derived from microalgae, primarily spirulina and astaxanthin.
Spirulina: Cyanotech is a leading producer of spirulina, a blue-green algae renowned for its rich nutrient profile. Spirulina is a complete protein source containing all essential amino acids, along with vitamins, minerals, and antioxidants. Cyanotech sells its spirulina under the brand name “Nutrex Hawaii Spirulina Pacifica” and markets it as a dietary supplement to support overall health and well-being. It’s often used by athletes, vegetarians, and individuals seeking to boost their nutritional intake.
Astaxanthin: The company also cultivates and extracts astaxanthin, a powerful antioxidant carotenoid derived from the microalgae Haematococcus pluvialis. Cyanotech markets its astaxanthin under the brand name “BioAstin Hawaiian Astaxanthin.” Astaxanthin is known for its potential anti-inflammatory, anti-aging, and eye health benefits. It’s used in dietary supplements targeting joint health, skin health, and cardiovascular health.
Production and Sustainability: Cyanotech’s production facility in Hawaii benefits from the region’s consistent sunlight, clean water, and favorable climate. The company emphasizes sustainable farming practices and utilizes a closed-pond system to minimize water usage and environmental impact. They also use a proprietary drying process to preserve the nutritional integrity of their algae products.
Financial Performance: As a publicly traded company, Cyanotech’s financial performance is subject to market fluctuations and competitive pressures. Investors and analysts track key metrics such as revenue, net income, gross margin, and earnings per share (EPS) using platforms like Yahoo Finance. Factors influencing Cyanotech’s financial results include demand for spirulina and astaxanthin, production yields, pricing strategies, and operating expenses. Its stock, being OTC, can be more volatile than those listed on major exchanges.
Market and Competition: Cyanotech operates in the growing dietary supplement market, which is driven by increasing consumer awareness of the health benefits of natural products. The company faces competition from other algae producers, as well as manufacturers of synthetic astaxanthin. Maintaining product quality, brand reputation, and competitive pricing are crucial for Cyanotech to succeed in the market.
Monitoring Cyanotech on Yahoo Finance: Yahoo Finance provides investors with a range of tools and information to monitor Cyanotech’s performance. This includes real-time stock quotes, historical price data, news articles, financial statements, analyst ratings (if available), and company profiles. By regularly monitoring these resources, investors can stay informed about Cyanotech’s business operations, market trends, and potential investment opportunities. Due to its OTC status, in-depth analyst coverage may be limited compared to larger, exchange-listed companies.